ProfileGDS4718 / 218699_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 64% 92% 70% 75% 90% 91% 78% 68% 70% 73% 79% 85% 88% 75% 76% 82% 82% 85% 87% 75% 79% 73% 72% 76% 90% 73% 83% 60% 88% 75% 88% 69% 65% 91% 92% 84% 83% 77% 94% 74% 88% 87% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3587563
GSM549102patient 115, normal, homogenized [OPG study]6.4101464
GSM549104patient 119, normal, homogenized [OPG study]9.6710492
GSM549108patient 138, normal, homogenized [OPG study]6.8012870
GSM549119patient 077, normal, homogenized [OPG study]7.3053375
GSM549133patient 032, cancer, homogenized [OPG study]9.3190790
GSM549139patient 042, cancer, homogenized [OPG study]9.3604891
GSM549099patient 107, normal, homogenized [OPG study]7.5250678
GSM549109patient 139, normal, homogenized [OPG study]6.725368
GSM549110patient 046, normal, homogenized [OPG study]6.8815970
GSM549114patient 063, normal, homogenized [OPG study]7.1584873
GSM549122patient 082, normal, homogenized [OPG study]7.7382179
GSM549134patient 033, cancer, homogenized [OPG study]8.4964985
GSM549136patient 036, cancer, homogenized [OPG study]8.8994888
GSM549140patient 044, cancer, homogenized [OPG study]7.4470175
GSM549111patient 047, normal, homogenized [OPG study]7.4720776
GSM549113patient 057, normal, homogenized [OPG study]8.2215982
GSM549132patient 031, cancer, homogenized [OPG study]8.0470182
GSM549137patient 038, cancer, homogenized [OPG study]8.5184585
GSM549142patient 047, cancer, homogenized [OPG study]8.2695987
GSM549100patient 110, normal, homogenized [OPG study]7.2399675
GSM549107patient 135, normal, homogenized [OPG study]7.711179
GSM549115patient 068, normal, homogenized [OPG study]7.2446873
GSM549116patient 072, normal, homogenized [OPG study]7.1185272
GSM549120patient 078, normal, homogenized [OPG study]7.4044876
GSM549131patient 030, cancer, homogenized [OPG study]9.1917590
GSM549118patient 074, normal, homogenized [OPG study]7.1784473
GSM549129patient 027, cancer, homogenized [OPG study]8.1993583
GSM549123patient 088, normal, homogenized [OPG study]6.1335260
GSM549124patient 006, cancer, homogenized [OPG study]8.7572488
GSM549126patient 015, cancer, homogenized [OPG study]7.3211375
GSM549128patient 025, cancer, homogenized [OPG study]8.8784488
GSM549103patient 117, normal, homogenized [OPG study]6.711669
GSM549117patient 073, normal, homogenized [OPG study]6.4361865
GSM549138patient 041, cancer, homogenized [OPG study]9.3933191
GSM549141patient 045, cancer, homogenized [OPG study]9.5699892
GSM549130patient 028, cancer, homogenized [OPG study]8.2708184
GSM549101patient 111, normal, homogenized [OPG study]8.1401483
GSM549105patient 128, normal, homogenized [OPG study]7.5375477
GSM549106patient 134, normal, homogenized [OPG study]10.0794
GSM549112patient 048, normal, homogenized [OPG study]7.2431274
GSM549125patient 011, cancer, homogenized [OPG study]8.8859888
GSM549127patient 024, cancer, homogenized [OPG study]8.7545487
GSM549135patient 035, cancer, homogenized [OPG study]8.6943686